Jazz Pharmaceuticals to Buy Cannabis-Based Drugmaker GW Pharma for $6.7 Billion

·

·

Jazz Pharmaceuticals to Buy Cannabis-Based Drugmaker GW Pharma for $6.7 Billion

The deal will strengthen Jazz’s neuroscience drug pipeline and add a potential blockbuster product in Epidiolex, which has the near-term potential to reach $1 billion in global annual sales, Jazz Chief Executive Bruce Cozadd said in an interview.
See Original Article

Electric moped startup Revel launches an EV charging business

The company said Wednesday that this new “Superhub,” which is located at the former Pfizer building in Brooklyn, will contain 30 chargers and be open to the public 24 hours a day. This will be the first in a network of Superhubs opened by Revel across New …
See Original Article

De Beers diamond sales surge after Christmas jewellery rush in US

The world’s biggest diamond miner made $650m from its rough stones last month, well above sales of $551m in early 2020, amounting to the highest sales since January 2018. Sales were …
See Original Article

Jeff Bezos will hand CEO role to Andy Jassy; Amazon reports record profit

The company is reaping huge profits as consumers, locked at home because of the COVID-19 crisis, become more reliant on both e-commerce and online services. That in turn has attracted regulatory scrutiny from lawmakers concerned about the power …
See Original Article

Humana posts Q4 loss after uptick in COVID-19 care, tests

Dive Brief: An uptick in COVID-19 testing and treatment led Humana to report a loss for the fourth quarter of 2020 of $2.07 per share and a pre-tax loss of $458 million …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.